SAN DIEGO, Jan. 7, 2025 /PRNewswire/ -- Robbins LLP reminds investors that a shareholder filed a class action against Kyverna Therapeutics, Inc. (NASDAQ: KYTX) and certain of the Company's senior executives and directors who signed the Registration Statement, effective February 7, 2024,...
Read More Details
Finally We wish PressBee provided you with enough information of ( Robbins LLP Reminds Kyverna Therapeutics, Inc. Investors of the Pending Securities Fraud Class Action Against KYTX )
Also on site :
- What to know about the trial of an ex-Michigan cop charged in the killing of a Black motorist
- Trump sees no red line that would change tariff policy - The Atlantic
- Could 100 Men Really Take on One Gorilla and Win? We Asked ChatGPT